SRC Sustained Release Caffeine Micro-Granules: Mechanism, Benefits, and Research Uses
Most caffeine hits fast, spikes hard, and crashes before the real work is done. That’s a problem if you’re running long experiments, deep-focus tasks, or testing complex stimulant stacks. SRC: Sustained Release Caffeine Micro-Granules (NEW) from Bulk Stimulants is a 50% caffeine-by-weight, natural sustained-release micro-granule technology engineered to deliver a smoother, extended caffeine curve. This article breaks down how it works, what the research on sustained-release caffeine shows, and how SRC can be used in advanced research and formulation settings.
Summary
Key facts about SRC sustained release caffeine micro-granules
SRC is a micro-granulated sustained release caffeine ingredient standardized at 50% caffeine by weight and manufactured using a melt-spray process that coats caffeine particles for controlled dissolution. The goal is a longer, smoother stimulant profile versus the sharp peak-and-drop associated with standard caffeine anhydrous.
How SRC differs from regular caffeine anhydrous and pills
Regular caffeine powders and tablets are immediate-release: they dissolve quickly, drive a rapid rise in plasma caffeine, and then taper off. SRC’s micro-granule delivery is engineered so that caffeine is released more slowly over time, reducing the initial burst and helping to limit abrupt changes in circulating levels.
Main research applications for sustained release caffeine
- Modeling long-duration alertness, vigilance, and cognitive performance.
- Comparing immediate-release vs. sustained-release stimulant pharmacokinetics.
- Testing prototype formulas that need smoother, multi-hour stimulation curves.
- Studying mood, perceived fatigue, and jitteriness under extended caffeine exposure.
Safety, compliance, and non-medical use disclaimer
Bulk Stimulants sells SRC as a research compound. It is not intended for use as a dietary supplement, food, or drug, and is not labeled for human or animal consumption. Appropriate PPE, calibrated milligram scales, and adherence to all relevant regulations and safe-handling practices are mandatory.
What Is SRC Sustained Release Caffeine Micro-Granules?
Product overview and specifications (50% caffeine by weight)
SRC is a sustained-release caffeine ingredient produced as free-flowing micro-granules that contain 50% natural caffeine and 50% release-modifying excipients. The granules are designed to be blended into powders, capsules, or stick packs, making it an attractive option for labs evaluating extended-release stimulant delivery systems.
Micro-granule format versus standard powdered or capsule caffeine
Standard caffeine anhydrous is a fine, immediate-release powder that dissolves rapidly. By contrast, SRC’s micro-granules are larger, denser units with a coated structure that slows water penetration and dissolution. This difference in physical form underpins the slower, more controlled release profile seen in sustained-release formulations.
Ingredient profile and how excipients control release rate
In a typical sustained-release caffeine system, caffeine is embedded in or coated with polymers and waxy excipients that create diffusion barriers. When exposed to GI fluids in experimental models, these excipients hydrate or soften gradually, allowing caffeine to diffuse out over several hours, rather than all at once. Adjusting excipient ratios and processing conditions lets formulators tune release rates for specific research goals.
How Bulk Stimulants positions SRC for research-only use
The product page emphasizes that SRC is a research ingredient intended for qualified users who understand stimulant pharmacology and formulation science. It is particularly relevant to projects focused on pharmacokinetics, multi-hour task performance, and comparison of delivery technologies, rather than casual consumer use.
How It Works
Caffeine’s basic mechanism as an adenosine receptor antagonist
Caffeine primarily acts by blocking adenosine A1 and A2A receptors in the central nervous system. Adenosine normally accumulates during wakefulness and promotes sleepiness; by antagonizing these receptors, caffeine reduces perceived fatigue and increases alertness and reaction speed. It also influences catecholamine release and neuronal firing rates, contributing to its psychostimulant profile.
How sustained release changes the caffeine absorption curve
Immediate-release caffeine typically produces a quick rise in plasma levels (Tmax < 1 hour), a relatively high peak concentration, and a more abrupt decline. Sustained-release formulations slow the rate of absorption, resulting in a higher Tmax, a lower early peak, and a more gradual decline in levels over 8–24 hours. Human pharmacokinetic studies on time-release caffeine show slower, more sustained plasma caffeine compared with standard caffeine, with similar overall exposure but a much flatter curve.
Role of micro-granule structure in dissolution and extended release
SRC-type systems use coated granules that dissolve in stages. Each granule acts like a tiny reservoir: water gradually penetrates the coating, caffeine diffuses out, and the dissolution front progresses from the outside inward. This reservoir behavior is what stretches the release over many hours versus the near-instantaneous dissolution of bare caffeine crystals.
Comparing acute spikes vs. smooth plasma levels in research models
A sharp spike in caffeine can be useful when testing rapid-onset effects but is more likely to produce jitteriness, anxiety, or a pronounced “crash” later on. Studies on sustained-release caffeine report lower jitter and tenseness scores, with participants feeling more alert and less tired across an extended window compared with immediate-release caffeine at equivalent total doses. For researchers, this opens the door to examining performance and mood under more stable stimulant exposure rather than roller-coaster kinetics.
Potential implications for focus, alertness, and mood in experimental setups
Because SRC-style formulations support prolonged plasma levels, they are particularly relevant in paradigms involving sleep restriction, long work shifts, or extended cognitive demand. Time-release caffeine studies show improvements in subjective alertness, reduced tiredness, and better overall mood ratings at several time points, suggesting that sustained exposure can be beneficial in maintaining performance across long sessions while limiting side effects.
Benefits
More stable stimulation and reduced “spike-and-crash” patterns in models
Sustained-release caffeine systems are specifically designed to reduce the initial surge in caffeine levels and the subsequent steep decline. Pharmacokinetic data show smoother concentration-time curves and fewer abrupt changes in plasma caffeine compared with immediate-release forms, which likely contributes to a less dramatic crash profile in experimental subjects.
Extended duration of effect for long protocols
In human studies, sustained-release caffeine ingredients have maintained elevated plasma caffeine and subjective alertness for up to 8–12 hours after a single dose. This extended window is highly relevant to research simulating long workdays, night shifts, or multi-hour cognitive testing batteries where a single immediate-release dose would wear off too quickly.
Dose customization and titration with micro-granulated powder
Because SRC is 50% caffeine by weight, researchers can precisely set target caffeine exposures by weighing the granules with a milligram-scale. This allows fine-grained titration (e.g., 50 mg vs. 100 mg vs. 150 mg caffeine equivalents) while still benefiting from the sustained-release profile dictated by the granule formulation.
Stack compatibility with other stimulants and nootropics in research
SRC can be combined, in controlled research settings, with nootropics and other stimulants to explore additive or synergistic effects. A sustained caffeine backbone paired with compounds such as cholinergic agents, L-theanine, or fast-onset stimulants can help researchers dissect multi-ingredient interactions while avoiding an overwhelming immediate caffeine hit.
Advantages of 50% caffeine content for precise measurement
Pure caffeine anhydrous can be challenging to handle due to its potency and fine particle size. SRC’s 50% concentration effectively “dilutes” the active within a structured granule, which can improve handling, reduce dust, and make it easier to measure relatively small caffeine doses accurately in a lab environment.
How To Use It
General dosage range guidelines for research settings (non-human)
Many human caffeine studies use 3–6 mg/kg body weight of caffeine for acute protocols, with sustained-release trials often employing single doses of 200–400 mg caffeine equivalents. In non-human or in vitro models, dosing should be scaled appropriately and justified based on the system being tested. SRC’s 50% potency means that 200 mg caffeine equivalent corresponds to 400 mg of granules, and so on.
Importance of milligram scales and accurate measuring equipment
Because caffeine is pharmacologically active at low milligram levels, accurate measurement is critical. A calibrated 0.001 g scale is strongly recommended when working with SRC. Researchers should also log batch numbers, storage conditions, and weighing records as part of basic quality assurance.
Timing strategies for sustained release caffeine experiments
In human time-release caffeine studies, dosing is typically done 30–60 minutes before the start of long-duration tasks, with performance and subjective measures tracked over 6–24 hours. Researchers can compare single-dose SRC curves against:
- Immediate-release caffeine at the same total dose.
- Split dosing of immediate-release caffeine across several hours.
- SRC plus a small immediate-release booster for dual-phase kinetics.
Example stack frameworks using SRC with other Bulk Stimulants compounds
In a research context, SRC might be evaluated in stacks such as:
| Research Goal | Example Components | Notes |
|---|---|---|
| Long-duration focus | SRC + L-theanine + choline donor | Study attention, mental fatigue, and error rates over several hours. |
| Stimulant comparison | SRC vs. immediate-release caffeine vs. stimulant blend | Compare pharmacokinetics, mood, and side-effect profiles. |
| Dual-phase energy curve | Small dose immediate-release caffeine + SRC backbone | Examine rapid onset plus extended maintenance of alertness. |
All such combinations must remain within safe research parameters and be conducted under appropriate oversight.
Storage, handling, and clumping considerations for micro-granules
SRC should be stored in a tightly sealed container, away from moisture and heat. As with many granulated ingredients, minor clumping due to humidity does not necessarily affect potency, but mass should always be verified by scale rather than by volume. Use clean, dry tools to transfer granules and avoid cross-contamination with other research materials.
Who It’s Best For
Researchers modeling long-duration focus and vigilance scenarios
SRC is well-suited to paradigms that simulate extended work shifts, long driving or monitoring tasks, and sleep-restriction challenges. Its sustained profile allows investigators to study performance trajectories under caffeine exposure that more closely matches real-world long-haul demands than a single short-lived spike.
Labs comparing immediate vs. sustained stimulant delivery profiles
When the question is “delivery system” rather than “ingredient,” SRC provides a model sustained-release stimulant to benchmark against standard caffeine. Researchers can track differences in pharmacokinetic parameters (Tmax, Cmax, AUC), mood ratings, cognitive scores, and side-effect profiles between release types.
Formulators exploring gentler stimulant curves in prototype blends
Formulation-focused teams can use SRC to prototype products intended to provide smooth, long-lasting stimulation rather than explosive, short-lived energy. Micro-granules can be incorporated into model blends and tested under controlled conditions before any regulatory or commercial decisions are made.
Experienced users familiar with caffeine pharmacology in research contexts
SRC is best suited to advanced experimental users and labs who already understand caffeine’s CNS effects, tolerance, and potential interactions. This audience is better equipped to design protocols, interpret results, and maintain safety when working with sustained-release stimulants.
Who should avoid SRC and stick to basic caffeine forms
SRC is not intended for casual caffeine consumers, self-experimenters without scientific training, or anyone looking for a simple “energy boost.” For non-research users, finished consumer products that use clearly labeled doses and are formulated under dietary-supplement regulations are more appropriate than raw research ingredients.
FAQs
How long can SRC sustained release caffeine last in typical models?
Time-release caffeine systems in human studies have shown meaningful differences in plasma caffeine levels and subjective alertness for up to 8–12 hours compared with immediate-release caffeine. Actual duration depends on dose, subject characteristics, and the specific sustained-release design, but SRC-style formulations are generally intended for multi-hour coverage rather than quick, 1–2 hour bursts.
How does SRC compare to regular caffeine anhydrous in potency?
On a per-milligram-of-caffeine basis, the stimulant effect is comparable; the difference lies in the time course, not the absolute amount of caffeine delivered. SRC is 50% caffeine by weight, so researchers must account for that when calculating dose, but total exposure over 24 hours can be similar to immediate-release caffeine at the same caffeine-equivalent dose, with a slower rise and more extended plateau.
Can SRC be combined with DMAA, DMHA, or Eria Jarensis in research?
In research settings, SRC may be included in multi-stimulant protocols to examine combined effects on mood, vigilance, and cardiovascular markers. However, stacking multiple powerful stimulants increases complexity and risk, so any such designs should be carefully justified, conservatively dosed, and conducted under appropriate ethical and safety oversight. SRC and all other stimulants from Bulk Stimulants are sold strictly for research use only.
Is SRC suitable for everyday consumer use or only for research?
SRC, as provided by Bulk Stimulants, is a research chemical, not a finished consumer product. It is not evaluated or approved as a dietary supplement or medication and should not be treated as one. Everyday users seeking a time-release caffeine effect should look for regulated, labeled products designed for public use, not raw lab ingredients.
What equipment is required to work with SRC safely and accurately?
At minimum, a milligram-accurate scale, appropriate PPE (such as gloves and eye protection), airtight containers, and basic lab instruments (scoops, spatulas, funnels) are needed. For pharmacokinetic or performance studies, additional infrastructure—such as blood sampling, analytical chemistry, or cognitive testing tools—may also be required.
Soft CTA
If your lab or formulation team needs a cleaner way to model long-lasting stimulant curves, a sustained-release caffeine backbone is a powerful tool. SRC: Sustained Release Caffeine Micro-Granules (NEW) from Bulk Stimulants delivers a standardized, 50% caffeine micro-granule system designed for research, making it easier to explore extended alertness, mood, and performance without the typical spike-and-crash profile.
References
- Tan, D. C. T., et al. Sustained-release of caffeine from a polymeric tablet matrix: An in vitro and pharmacokinetic study. Eur J Pharm Biopharm. 2007.
- González, A. M., et al. Effects of time-release caffeine on repeated sprint performance, reaction time, and mood. J Int Soc Sports Nutr. 2015.
- González, A. M., et al. Pharmacokinetics of caffeine administered in a time-release versus regular form. J Int Soc Sports Nutr. 2014.
- Morde, A., et al. Pharmacokinetic profile of a novel sustained-release caffeine with extended benefits on alertness and mood: A randomized double-blind, single-dose, active-controlled crossover study. Clin Nutr ESPEN. 2021.
- Song, X., et al. Caffeine: A multifunctional efficacious molecule with multidimensional mechanisms and potential therapeutic applications. Int J Mol Sci. 2024.
